ALYSSA CIRUCCI: Open Payments
NPI 1144855214 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 27 payments from 14 companies in 2025. Trend: 2023 $816 · 2024 $998 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $69 |
| ABBVIE INC. | 4 | $64 |
| Amgen Inc. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $52 |
| UCB, Inc. | 2 | $36 |
| Incyte Corporation | 2 | $36 |
| GENZYME CORPORATION | 1 | $21 |
| Botanix SB Inc | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: OTEZLA, SKYRIZI, Bimzelx, OPZELURA, Winlevi, HADLIMA, DUPIXENT, ILUMYA.
Industry payments across NJ — which companies pay providers there.
